MedTrace Logo

Effect of IASTM in Children With Diplegia

NCT07289386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-12-17

No results posted yet for this study

Summary

The aim was to evaluate the effect of using IASTM on passive ROM of the lower limbs and joint angles during gait in children with spastic diplegic CP. Methods: Thirty children with diplegic CP were randomly divided into 2 groups: a control group (which received a selected physical therapy program) and the study group (which received IASTM therapy in addition to the selected physical therapy program). They were treated three times weekly for six weeks. Passive ROM and active ROM during gait were assessed using a digital goniometer and Kinovea analysis software, respectively, before and after the proposed treatment period.

Conditions

  • Cerebral Palsy (CP)

Interventions

PROCEDURE

IASTM therapy in addition to the selected physical therapy program

The designed IASTM therapy was applied for 8-10 minutes per session, three times per week (every other day), for six successive weeks in addition to the selected physical therapy program was applied for one hour per session, three times per week (every other day), for six successive weeks

PROCEDURE

selected physical therapy program

The selected physical therapy program was applied for one hour per session, three times per week (every other day), for six successive weeks

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Mai E. Abbass · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07289386 on ClinicalTrials.gov